advertisement

---

Goodkin ML 9

Showing records 1 to 9 | Display all abstracts from Goodkin ML

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Craven ER
Drugs 2020; 80: 167-179

---

85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort R; Paula JS
Clinical Therapeutics 2020; 42: 263-275

---

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Walters T; Christie WC
Drugs 2020; 80: 167-179

---

85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Lopes Silva MJ; Della Paolera M
Clinical Therapeutics 2020; 42: 263-275

---

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Day DG
Drugs 2020; 80: 167-179

---

85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Kim T
Clinical Therapeutics 2020; 42: 263-275

---

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Lewis RA; Goodkin ML
Drugs 2020; 80: 167-179

---

85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Chen MY; Goodkin ML
Clinical Therapeutics 2020; 42: 263-275

---

84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
Chen M; Wangsadipura V; Robinson MR; Bejanian M;
Drugs 2020; 80: 167-179

---